Want to see TSE:DM full AI Analyst Report?
DM Stock Chart & Stats
C$0.09
>-C$0.01(-50.00%)
At close: 4:00 PM EST
C$0.09
>-C$0.01(-50.00%)
Day’s Range― - ―
52-Week RangeC$0.04 - C$0.15
Previous CloseN/A
Volume34.10K
Average Volume (3M)89.95K
Market Cap
C$6.10M
Enterprise ValueC$6.51
Total Cash (Recent Filing)C$1.88M
Total Debt (Recent Filing)C$2.67M
Price to Earnings (P/E)―
Beta2.74
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding152,586,000
10 Day Avg. Volume133,964
30 Day Avg. Volume89,955
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.63
Price to Sales (P/S)1.11
P/FCF Ratio-2.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Industry Positioning (AI & Cybersecurity)Datametrex combines AI/ML analytics with cybersecurity offerings, aligning with long-term structural demand for data-driven security and analytics. This product mix supports durable enterprise and government contracts, recurring services, and cross-sell opportunities that can sustain revenue beyond short-term cycles.
Modest TTM Revenue GrowthPositive trailing-twelve-month revenue growth indicates the company is achieving market traction for its AI and services offerings. While growth is modest, sustained topline expansion provides a foundation to scale margins and amortize fixed costs if the firm stabilizes operations and converts engagements into recurring contracts.
Improved Leverage And Equity BufferLeverage has normalized to moderate levels and equity now exceeds debt, improving financial flexibility. This stronger balance-sheet posture lowers near-term solvency risk, makes external financing less dilutive or costly, and supports continued investment in product development or sales execution over the coming months.
Bears Say
Severely Negative ProfitabilityDeep negative gross profit and net margins indicate unit economics are currently unsustainable; the business is not yet generating positive contribution from core offerings. Structural profitability weakness impairs the company's ability to self-fund growth, undermines reinvestment capacity, and raises execution risk unless margins materially improve.
Negative Operating And Free Cash FlowOngoing cash burn means operations consume cash rather than produce it, forcing reliance on external financing or asset sales. Even with improved trends year-over-year, failure to reach positive operating cash flow within months can lead to dilutive capital raises or curtailed R&D and sales investment, limiting sustainable growth.
Deeply Negative Returns On EquityNegative ROE shows the company is destroying shareholder value, which can erode the equity base over time. Persistent negative returns make future fundraising harder and more expensive, constrain strategic options, and increase the risk that sustained losses eventually require significant balance-sheet corrective actions.
Datametrex AI News
DM FAQ
What was Datametrex AI Limited’s price range in the past 12 months?
Datametrex AI Limited lowest stock price was C$0.04 and its highest was C$0.15 in the past 12 months.
What is Datametrex AI Limited’s market cap?
Datametrex AI Limited’s market cap is C$6.10M.
When is Datametrex AI Limited’s upcoming earnings report date?
Datametrex AI Limited’s upcoming earnings report date is Aug 05, 2026 which is in 14 days.
How were Datametrex AI Limited’s earnings last quarter?
Datametrex AI Limited released its earnings results on Mar 09, 2026. The company reported -C$0.018 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Datametrex AI Limited overvalued?
According to Wall Street analysts Datametrex AI Limited’s price is currently Overvalued.
Does Datametrex AI Limited pay dividends?
Datametrex AI Limited does not currently pay dividends.
What is Datametrex AI Limited’s EPS estimate?
Datametrex AI Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Datametrex AI Limited have?
Datametrex AI Limited has 152,586,000 shares outstanding.
What happened to Datametrex AI Limited’s price movement after its last earnings report?
Datametrex AI Limited reported an EPS of -C$0.018 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Datametrex AI Limited?
Currently, no hedge funds are holding shares in TSE:DM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Datametrex AI Limited
Datametrex AI Limited, alongside its various divisions, specializes in leveraging proprietary machine learning and artificial intelligence technologies to gather, process, and present both structured and unstructured data. The company conducts its operations across Canada and South Korea. Its business is strategically organized into two main sectors: AI and Technology, and Health Security. Within the Health Security segment, Datametrex delivers a comprehensive suite of medical services, including support related to COVID-19, personalized concierge medicine, and virtual telehealth consultations. Concurrently, its AI and Technology division provides expertise in big data analytics, artificial intelligence development, and integrated system solutions. The company also supplies COVID-19 diagnostic kits. Furthermore, its offerings encompass specialized platforms such as NexaSecurity, designed for social media discovery and monitoring; Nexalogy's Automated Social Media Reporting Technologies; and dedicated Datametrex EV solutions for electric vehicles. Additionally, Datametrex developed the Medi-Call health application, a subscription-based service that facilitates connections between patients and medical professionals. This app enables technology-driven e-health and m-health services, including the issuance of prescriptions and the arrangement of in-person doctor visits at a patient's home or workplace. Datametrex AI Limited's corporate headquarters are situated in Toronto, Canada.